{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:19:16Z","timestamp":1764181156112,"version":"3.46.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13312-025-00182-7","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T03:28:20Z","timestamp":1758857300000},"page":"899-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary Tyrosinemia Type 1: Success and Challenges in Indian Subcontinent"],"prefix":"10.1007","volume":"62","author":[{"given":"Samannay","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-4084","authenticated-orcid":false,"given":"Vikrant","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikrant Bihari","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chhagan","family":"Bihari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"182_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40272-019-00364-4","volume":"21","author":"WG van Ginkel","year":"2019","unstructured":"van Ginkel WG, Rodenburg IL, Harding CO, Hollak CEM, Heiner-Fokkema MR, van Spronsen FJ. Long-term outcomes and practical considerations in the pharmacological management of tyrosinemia type 1. Paediatr Drugs. 2019;21:413\u201326.","journal-title":"Paediatr Drugs"},{"key":"182_CR2","unstructured":"Sniderman King L, Trahms C, Scott CR. Tyrosinemia Type I. [Updated 2017 May 25]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 2006. pp. 1993\u20132025."},{"key":"182_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3138\/canlivj-2023-0018","volume":"7","author":"M Kehar","year":"2024","unstructured":"Kehar M, Sen Sarma M, Seetharaman J, Jimenez Rivera C, Chakraborty P. Decoding hepatorenal tyrosinemia type 1: unraveling the impact of early detection, NTBC, and the role of liver transplantation. Can Liver J. 2024;7:54\u201363.","journal-title":"Can Liver J"},{"key":"182_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","volume":"9","author":"S Mayorandan","year":"2014","unstructured":"Mayorandan S, Meyer U, Gokcay G, et al. Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J Rare Dis. 2014;9:107.","journal-title":"Orphanet J Rare Dis"},{"key":"182_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jceh.2020.07.002","volume":"11","author":"S Mirani","year":"2021","unstructured":"Mirani S, Poojari V, Shetty NS, Shah I. Outcome of tyrosinemia type 1 in Indian children. J Clin Exp Hepatol. 2021;11:9\u201313.","journal-title":"J Clin Exp Hepatol"},{"key":"182_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12098-021-03826-1","volume":"89","author":"J Menon","year":"2022","unstructured":"Menon J, Shanmugam N, Valamparampil JJ, et al. Liver transplantation: a safe and definitive alternative to lifelong nitisinone for tyrosinemia type 1. Indian J Pediatr. 2022;89:438\u201344.","journal-title":"Indian J Pediatr"},{"key":"182_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2012.05.022","volume":"107","author":"J Larochelle","year":"2012","unstructured":"Larochelle J, Alvarez F, Bussi\u00e8res JF, et al. Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Qu\u00e9bec. Mol Genet Metab. 2012;107:49\u201354.","journal-title":"Mol Genet Metab"},{"key":"182_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","volume":"31","author":"A Masurel-Paulet","year":"2008","unstructured":"Masurel-Paulet A, Poggi-Bach J, Rolland MO, et al. NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis. 2008;31:81\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"182_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ped.12503","volume":"57","author":"AC Zeybek","year":"2015","unstructured":"Zeybek AC, Kiykim E, Soyucen E, et al. Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience. Pediatr Int. 2015;57:281\u20139.","journal-title":"Pediatr Int"},{"key":"182_CR10","doi-asserted-by":"publisher","first-page":"117955652412361","DOI":"10.1177\/11795565241236176","volume":"18","author":"SA Khan","year":"2024","unstructured":"Khan SA, Fakih M, Taufiq N, Ahmerin A, Bangash A, Iqbal Malik M. Clinical spectrum of hereditary tyrosinemia type 1 in a cohort of Pakistani children. Clinical Medicine Insights: Pediatrics. 2024;18:11795565241236176.","journal-title":"Clinical Medicine Insights: Pediatrics"},{"key":"182_CR11","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.ejmg.2024.104970","volume":"71","author":"Z Beyzaei","year":"2024","unstructured":"Beyzaei Z, Goudarzi Z, Dehghani SM, et al. Mutation spectrum of tyrosinemia type I in Iran, a retrospective cohort study. Eur J Med Genet. 2024;71:104970.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"182_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1172-4-28","volume":"15","author":"D Cassiman","year":"2009","unstructured":"Cassiman D, Zeevaert R, Holme E, Kvittingen EA, Jaeken J. A novel mutation causing mild, atypical fumarylacetoacetase deficiency (tyrosinemia type I): a case report. Orphanet J Rare Dis. 2009;15(4):28.","journal-title":"Orphanet J Rare Dis"},{"key":"182_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/humu.23047","volume":"37","author":"PR Blackburn","year":"2016","unstructured":"Blackburn PR, Hickey RD, Nace RA, et al. Silent tyrosinemia type I without elevated tyrosine or succinylacetone associated with liver cirrhosis and hepatocellular carcinoma. Hum Mutat. 2016;37:1097\u2013105.","journal-title":"Hum Mutat"},{"key":"182_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/ijns9040066","volume":"9","author":"AM Dijkstra","year":"2023","unstructured":"Dijkstra AM, Evers-van Vliet K, Heiner-Fokkema MR, et al. A false-negative newborn screen for tyrosinemia type 1-need for re-evaluation of newborn screening with succinylacetone. Int J Neonatal Screen. 2023;9:66.","journal-title":"Int J Neonatal Screen"},{"key":"182_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jchromb.2017.11.031","volume":"1072","author":"J Sundberg","year":"2018","unstructured":"Sundberg J, Wibrand F, Lund AM, Christensen AM. Simultaneous quantification of succinylacetone and nitisinone for therapeutic drug monitoring in the treatment of tyrosinemia type 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1072:259\u201366.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"182_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0046-8177(03)00406-4","volume":"34","author":"SI Demers","year":"2003","unstructured":"Demers SI, Russo P, Lettre F, Tanguay RM. Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. Hum Pathol. 2003;34:1313\u201320.","journal-title":"Hum Pathol"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-025-00182-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:15:34Z","timestamp":1764180934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-025-00182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s13312-025-00182-7","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"type":"print","value":"0019-6061"},{"type":"electronic","value":"0974-7559"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from Institutional Ethics Committee, Institute of Liver and Biliary Sciences; Ref No: IEC\/2025\/117\/MA11, dated March 28, 2025.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}